APA (7th ed.) Citation

CA, P., NC, M., J, D., 3rd, W. E., & JS, L. (2015). Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. Regenerative medicine, 10(8), 939. https://doi.org/10.2217/rme.15.57

Chicago Style (17th ed.) Citation

CA, Priest, Manley NC, Denham J, Wirth ED 3rd, and Lebkowski JS. "Preclinical Safety of Human Embryonic Stem Cell-derived Oligodendrocyte Progenitors Supporting Clinical Trials in Spinal Cord Injury." Regenerative Medicine 10, no. 8 (2015): 939. https://doi.org/10.2217/rme.15.57.

MLA (9th ed.) Citation

CA, Priest, et al. "Preclinical Safety of Human Embryonic Stem Cell-derived Oligodendrocyte Progenitors Supporting Clinical Trials in Spinal Cord Injury." Regenerative Medicine, vol. 10, no. 8, 2015, p. 939, https://doi.org/10.2217/rme.15.57.